Intestinal Immunity in Neurologic Disease
Yale University · with National Institutes of Health (NIH), Chan Zuckerberg Biohub · NCT06329453
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- August 2, 2022
- Record last updated
- May 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to ascertain the functional profiles of the immune cells within the gastrointestinal tract and to determine how these cells contribute to autoimmune and neurologic diseases.
Being studied: Colon Tissue Biopsy
Conditions: Multiple Sclerosis; Parkinson Disease; REM Sleep Behavior Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18 and up
ONE of the following
- Recommended to under a screening colonoscopy (+/- upper endoscopy) as part of standard of care. This includes healthy individuals as well as those with neurologic and/or autoimmune diseases. OR
- Willing to undergo research colonoscopy (+/- upper endoscopy) for research
Exclusion Criteria
- Currently pregnant. Women of childbearing potential would perform a point of care urine pregnancy test prior to colonoscopy/endoscopy.
- Known or suspected, chronic inflammatory gastrointestinal disease (e.g. inflammatory bowel disease)
- Known, acute or chronic infections
- Systemic antibiotic (PO or IV) use within 3 months of colonoscopy
- Systemic corticosteroid use (equivalent of prednisone 10 mg per day or higher for >5 days) within 2 weeks of colonoscopy
- Malignancy, diagnosed or treated within the last 5 years
- Probiotic use within 2 weeks of procedure
- History of major GI surgery (e.g. colon resection, gastric bypass)
- Bleeding disorder, or on anticoagulant medication
- Other medical condition that, in the judgement of the investigator, would lead to higher-than-expected risks of biopsy
- Allergy to MAC anesthesia or other drugs used pursuant to standard of care for biospecimen collection
Recruiting US locations
Yale MS Clinic
North Haven, CT 06473
Site contact: Cynthia Marques · 2032876100 · cynthia.marques@yale.edu
Study contacts (from the official record)
- Cynthia Marques · 2032876100 · cynthia.marques@yale.edu
- Dimitri Duvilaire · 2032876100 · dimitri.duvilaire@yale.edu
Similar studies in Connecticut
All sleep studies in Connecticut →- RecruitingHealthy volunteersEarly Phase 1
Mechanistic Studies of Psilocybin in Headache Disorders
Yale University
- Location
- West Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingPhase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Janssen Research & Development, LLC
- Location
- Farmington, CT + 41 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Merck Sharp & Dohme LLC
- Location
- New Haven, CT + 12 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 40+